(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

RIGENASE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

RIGENASE

ST13

US500000079192250

Classe

1, 3, 5

Pedido

79192250

Registro

5278789

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

39

Atualização mais recente

04/01/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 3, 5

Data de depósito

14/04/2016

Data de registro

05/09/2017

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

22/03/2024

Última transação

04/01/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

09

Localização do titular

IT

Examinador

HELLMAN, ELI

Unidade examinadora

M30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

FARMACEUTICI DAMOR S.P.A.

Representantes

Lawrence E. Abelman Abelman Frayne & Schwab

Classificação técnica

Classes Nice

Classe 1Classe 3Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Botanical extracts for use in the production of pharmaceuticals that are only sold over the counter; botanical extracts for use in making cosmetics; saccharides as raw materials for the manufacture of pharmaceutical products that are only sold over the counter; saccharides as raw materials for the manufacture of cosmetic products; chemical additives for use in the manufacture of cosmetics; chemical additives for use in the manufacture pharmaceuticals that are only sold over the counter; chemical preparations for use in the manufacture of cosmetic products; chemical preparations for use in the manufacture of pharmaceutical product that are only sold over the counter

Classe 3

Cosmetic preparations for skin carein particular exfoliant creamsbarrier creamsanti-aging creamsbody creamsage spot reducing creams and creams for the reduction of cellulitewrinkles and stretch marks; cosmetic creamsincluding hand creams and moisturizing creamslotions and gels for skinhair and face; Skin whitening creams; pomades for cosmetic purposes; Soaps; cosmetic preparations for bath; shaving soap; beauty masks; Mouthwashesnot for medical purposes; cosmetics; dentifrices; disinfectant soap; depilatory preparations; oils for cosmetic purposes; lotions for cosmetic purposes; Cleansing milk for toilet purposes; medicated soap; shaving preparations; cosmetic sun-tanning preparations; after-shave lotions; breath freshening sprays; douching preparations for personal sanitary or deodorant purposes; massage gels other than for medical purposes; balms other than for medical purposesfor use on skin and lips; bath preparationsnot for medical purposes; tissues impregnated with make-up removing preparations

Classe 5

Pharmaceutical preparations in the nature of therapeutic topical creams for skin carefor the treatment of damaged skinfor the treatment of dermatological diseases and disorders all of the foregoing sold only over the counter; pharmaceutical creams in the nature of therapeutic topical creams for the treatment of gynecological diseases and disorders all of the foregoing sold only over the counter; pharmaceutical preparations in the nature of over the counter therapeutics intended to treat diseases and disorders of mucous membranesincluding oral and anal mucousa; dermatological products for medical usecreamsointmentsgels and lotions for the treatment of stretch-marks and psiorasis and for biorevitalizing treatments all of the foregoing sold only over the counter; dermatological pharmaceutical products sold only over the counter; adhesive plasters for medical purposes; frostbite salve for pharmaceutical purposes sold only over the counter; hemorrhoid preparations; antiseptics; bacteriological preparations for medical and veterinary use; bath preparations for medical purposes; therapeutic preparations for the bath; bandages for dressings; balms for medical purposes; preparations for the treatment of burns; pharmaceutical preparations for the treatment of wounds and for the treatment of skin and hair disorders; lint for medical purposes; collyrium; cotton for medical purposes; chilblain preparations; detergents for medical purposes; medical dressings; disinfectants for hygiene purposes; flour for pharmaceutical purposes sold only over the counter; gauze for dressings; medicinal oils; medicinal herbs; lotions for pharmaceutical therapeutic purposeslotions for the treatment of wounds and for the treatment of skin and hair disorders all of the foregoing sold only over the counter; pomades for medical purposes; tinctures of iodine for medical purposes; ointments for pharmaceutical therapeutic purposesointments for the treatment of wounds and for the treatment of skin and hair disorders all of the foregoing sold only over the counter; sanitary towels; suppositories; medicated remedies for perspiration; sunburn ointments; medicines for dental purposes; medicated tissues impregnated with pharmaceutical therapeutic lotions sold only over the counter; vaginal washes; adjuvants for medical purposes; douching preparations for medical purposes; cooling sprays for medical purposes; personal sexual lubricants; disinfectants; acne treatment preparations; cotton sticks for medical purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

39 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

04/01/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

12/12/2024

INPC

INVALIDATION PROCESSED

12/12/2024

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

23/11/2024

C71T

CANCELLED SECTION 71

22/03/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/09/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/04/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

26/01/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

16/12/2017

FIMP

FINAL DISPOSITION PROCESSED

15/12/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/12/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

05/09/2017

DOCK

ASSIGNED TO EXAMINER

31/07/2017

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

30/07/2017

CHPB

CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED

30/05/2017

APET

ASSIGNED TO PETITION STAFF

25/05/2017

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

22/05/2017

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

05/04/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

21/03/2017

PUBO

PUBLISHED FOR OPPOSITION

21/03/2017

GPNX

NOTIFICATION PROCESSED BY IB

17/03/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/03/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/03/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/03/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

14/02/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/02/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/01/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/01/2017

ALIE

ASSIGNED TO LIE

19/01/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/12/2016

RFNT

REFUSAL PROCESSED BY IB

21/10/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

30/09/2016

RFRR

REFUSAL PROCESSED BY MPU

30/09/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

29/09/2016

CNRT

NON-FINAL ACTION WRITTEN

28/09/2016

MAFR

APPLICATION FILING RECEIPT MAILED

28/09/2016

DOCK

ASSIGNED TO EXAMINER

24/09/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/09/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

22/09/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace RIGENASE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.